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OBJECTIVE: The present literature review aims to highlight gaps in the treatment of preventative mother-
to-child HIV transmission and the risk factors in Brazil.
METHODS: Among the 425 articles identified in SciELO and PubMed searches, 59 articles published between 1994
and 2016 were selected for reading and data extraction, and 33 articles were included in the present review.
RESULTS: The rates of vertical HIV transmission described in the studies varied widely, from 1.8% to 27.8%, with
a significant reduction over the years. However, recent rates were also found to be variable in different regions
of Brazil, and despite the significant reduction in mother-to-child transmission, many gaps remain in prevention
services. A failure to attend prenatal care is the main factor associated with the increased risk of vertical
transmission of HIV, hindering early maternal diagnosis and the completion of preventative measures during the
prenatal period and, often, the peripartum and postnatal periods. A small number of studies discussed the
sociodemographic factors, including a low level of education for pregnant women and the inadequacies of
health services, such as difficulties scheduling appointments and undertrained staff, associated with vertical
transmission. As such, the current challenge is to better define the sociodemographic and infrastructural factors
that increase the risk of mother-to-child transmission of HIV to provide the necessary investments to promote an
earlier inclusion of these populations in prevention services.
CONCLUSIONS: This review may serve as a guide for future programs to focus efforts on the prevention of
vertical HIV transmission.
KEYWORDS: Vertical transmission; HIV; Missed Opportunities; Prevention; Children.
’ INTRODUCTION
The world has committed to ending the AIDS epidemic by
2030 (1). To achieve this goal, increased investments in stra-
tegies (1) to prevent new cases of the disease and adequate
treatments for individuals already infected with the virus
are required (2). Among these strategies, it is critical that
substantial efforts be made to reduce vertical transmission
of HIV, as this is the main route by which children under 5
become infected (3).
In the absence of adequate prophylaxis, mother-to-child
transmission (MTCT) occurs in 20-45% of children born to HIV-
infected mothers (4). While the main periods of transmission
are gestation and peripartum, approximately 7-22% of cases
of vertical transmission occur in the postpartum period
through breastfeeding (5,6). Fortunately, in the last 30 years,
many advances have been made in the prevention of MTCT.
Currently, with the implementation of all the preventative
interventions advocated by the National STD and AIDS
Program, it is possible to reduce the rates of vertical trans-
mission of HIV to less than 2% (7-9). In addition to the use of
antiretrovirals (ARVs), these recommendations include an
elective cesarean section for pregnant women with a viral
load above 1,000 copies/ml or an unknown viral load, as
well as the inhibition of lactation and the utilization of infant
formula.
In Brazil, free and universal access to combined antire-
troviral therapy (ART) has been offered to pregnant women
since 1997. Beginning in 2012, Brazil began offering lifelong
triple ART to HIV-infected pregnant women (Option B+),
and by 2013, Brazil adopted the Treatment as Prevention
(TasP) approach and now offers free ART to all HIV-infected
adults. Additionally, since 2002, formula has been provided
free of charge during the first six months of a child’s life (9).
To improve access and promote the use of these prophylactic
interventions, the Brazilian Ministry of Health introducedDOI: 10.6061/clinics/2019/e318
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the ‘‘Stork Network’’ (Rede Cegonha) in 2011 to expand and
strengthen nationwide MTCT prevention services (10).
Despite advances in preventing MTCT, data have shown
that in 2015, 1.8 million children globally were living with
HIV, and more than 150,000 were newly infected (1). In
Brazil, 7,901 HIV-infected pregnant women were reported in
2015—31.9% in the southeast, 29.6% in the south, 20.9% in
the northeast, 11.8% in the north and 5.8% in the central-west
(3). In the same year, 62 cases of HIV infection were reported
in children under 5 throughout the country (3), and it was
estimated that the frequency of MTCT nationally was still
between 15 and 24% (11).
This literature review was carried out with the objective
of identifying barriers and facilitators to implement pro-
phylaxis and, consequently, to reduce MTCT in Brazil. The
study presents the vertical transmission rates of HIV and
the missed opportunities in the prevention of MTCT in the
different regions of Brazil, aiming to highlight the diversities
and the demands of each region, as well as over time; the
overall aim was to understand the impact of evolving
national policy and services for MTCT over the years.
’ METHODS
Articles were identified in PubMed using the following
search terms: ‘‘Risk Factors Vertical Transmission Brazil’’,
‘‘Risk Factors Mother-to-Child Transmission’’, ‘‘Vertical Trans-
mission HIV Brazil’’ and ‘‘Mother-to-Child Transmission HIV
Brazil.’’ We also searched for articles in SciELO using the
following terms: ‘‘Transmissão vertical HIV Brasil’’, ‘‘Fatores
de risco transmissão vertical Brasil’’, ‘‘Transmissão materno
infantil HIV Brasil’’ and ‘‘Fatores de risco transmissão materno
infantil Brasil.’’ Articles published between 1994 and 2016 in
English and Portuguese were considered for inclusion in the
review.
Among the 425 search results, 59 articles were selected
(according to the title and abstract) for reading and extra-
cting data. The exclusion criteria were an inappropriate metho-
dology and articles that did not present information on rates
and/or factors directly associated with MTCT. A total of 33
analytical and descriptive studies were included, from which
it was possible to obtain information on the rates of vertical
HIV transmission in the different regions of Brazil, the main
factors associated with the increase in these rates, and the
difficulties faced in providing prophylaxis. Figure 1 - Flow-
chart of the selection of articles included in the literature
review - shows the selection process of the articles. In addi-
tion, classic literature articles on the topic and protocols were
also read and are cited in the present review.
For presentation of the results of our review, missed
opportunities and the risk factors associated with MTCT
were grouped by perinatal period as follows: prenatal care,
peripartum care, and postnatal care. Sociodemographic
risk factors and inadequacies in MTCT delivery were also
evaluated.
’ RESULTS
Rates of HIV transmission by geographical region
A total of 33 articles were selected based on an evaluation
of the methodology and the results of interest. Among the
included studies, 24 had information on the rates of vertical
transmission of HIV according to the region of the country.
Table 1 highlights these data.
The rates of MTCT in Brazil varied from 1.8% in a study by
Lemos et al. (14) in Sergipe to 27.8% in a study by Turchi et al.
(30) in Goiânia. This divergence may be explained by the
period of the studies, the former being conducted between
2010 and 2011, and the latter conducted between 1995 and
2001. Supporting this, it was possible to observe a substantial
reduction in MTCT rates over the years (Table 2). In a south-
east capital of the country, for example, there was an 85%
reduction in the MTCT rates between 1998 and 2005 (24).
Factors associated with increased vertical
transmission rates
1) Prenatal care. Diagnosis of maternal HIV infection
during the prenatal period is critical to applying complete
preventative care for MTCT. In Brazil, following the proto-
col of the Ministry of Health, HIV testing of the mother
by ELISA or a rapid test should be carried out in the first
trimester and, in the case of a negative first test, should be
repeated in the third trimester. If the mother is infected with
HIV, she should be counseled about preventative treatments
and receive joint monitoring in a basic health unit and in an
HIV reference unit (9).
In different regions of the country, failure to attend
prenatal care (13,17,37), late maternal diagnosis (13,37), and
an incomplete ART regimen during pregnancy (13,16,17,37)
were highlighted as significant risk factors for MTCT.
A retrospective study conducted between 2000 and 2009 in
the northeast of the country in the state of Pernambuco
demonstrated the importance of prenatal care in the pro-
phylaxis of vertical HIV transmission. Pregnant women who
underwent prenatal care had only an 8.1% (68/845) MTCT
rate, whereas in the group that did not perform prenatal care,
this number increased to 27.1% (19/70) (16). It is important
to note that 7.7% (70/915) of the pregnant women remained
without prenatal care in this study.
Concerning data on prenatal care attendance was shown
in this same region through a cross-sectional study carried
out at a public maternity hospital in Salvador in 2001, in
which 29.6% of the women stated that they had not attended
any prenatal care (38). Similarly, inadequate rates of prena-
tal attendance were also observed in studies conducted in
the southeast region. Nishimoto et al. (19) showed that in a
cohort study from 1997 to 2000 in the state of São Paulo,
20.4% (29/142) of the HIV-infected pregnant women parti-
cipating in the study did not attend prenatal care. More
recently, in Rio de Janeiro, a sample of 40 HIV-infected parti-
cipants born in 2008 who had not received HIV transmission
prophylaxis was evaluated. Of these women, 30% did not
attend prenatal care, 50% had 1 to 5 consultations, and 20%
had 6 or more consultations (39). Another study in Rio de
Janeiro, evaluating a cohort of HIV-infected pregnant women
between 1997 and 2014, found that 14% of these women did
not attend any prenatal care (40). Two studies we identified
evaluated prenatal care attendance over the years and obser-
ved a modest increase in attendance rates. A study of 1364
HIV-infected pregnant women between 2000 and 2009 across
the northeast state of Ceará found an increase in prenatal
attendance over the study period, although just 84.5% of
women had attended any prenatal care in the final study
year (37). In the Rio de Janeiro cohort of HIV-infected preg-
nant women from 1997 to 2014, prenatal care attendance
increased over the study period, although again just 83.3% of
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HIV-infected pregnant women had at least one prenatal visit
in 2014 (40).
The period of maternal HIV diagnosis also showed a direct
association with the rates of MTCT. A study carried out
from 1995-2001 in Goiânia (30) showed that the risk of
transmission was significantly higher in women diagnosed
postpartum (40.8%, 62/152) than in women diagnosed
prepartum (4.8%, 8/166). In the northeast region, Cruz
Gouveia et al. (16) demonstrated that, of the pregnancies
with a maternal diagnosis made before or during gestation
between 2000 and 2009, the rate of infected children was
4.7%; when the diagnosis was made during or after delivery,
this rate increased to 25.8%. In the southeast region, Lovero
et al. (40) found that, in a cohort of HIV-infected pregnant
women from Rio de Janeiro between 1997 and 2014, a
postpartum diagnosis was associated with an eleven-fold
increase in the likelihood of MTCT.
Across the different regions of Brazil, the rates of prenatal
diagnosis varied considerably by region. Two retrospective
studies conducted in the central-western and southeast
regions of the country between 1996-2001 and 1999-2004, res-
pectively, showed that most HIV-infected pregnant women
knew about the diagnosis before or during prenatal care, but
there were still women diagnosed only at the time of delivery
(29,21). In the first study, 51.3% (39/76) of pregnant women
learned about their HIV status during the prenatal period,
while 40.8% (31/76) had the diagnosis prior to gestation. The
remaining six women (7.9%) learned of the diagnosis at the
time of delivery through HIV rapid testing performed during
delivery. In the second study, in a sample of 44 pregnant
women, 47.7% were aware of their diagnosis before gesta-
tion, 50% during gestation and 2.3% at the time of delivery.
More concerning data were demonstrated in a study by
Nishimoto et al. (20) conducted from 1997 to 2000 in the
southeast region, in which only 51.8% of the HIV-infected
pregnant women were tested for HIV infection during pre-
natal care.
More recently, in a study conducted in the northern
region of Brazil between 1999 and 2011, 32.3% (297/919) of
pregnant women already knew their HIV diagnosis before
pregnancy, 48.9% (449/919) were diagnosed during prenatal
care, 7.3% (67/919) were diagnosed during the intrapartum
period, and 11.5% (106/919) only had this diagnosis in the
postpartum period, missing any opportunity for prophylactic
Figure 1 - Flowchart of the selection of articles included in the literature review.
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treatment (13). Similar results were identified in a study of
HIV-infected pregnant women from Rio de Janeiro between
1997 and 2014, in which 11.5% (50/435) did not receive an
HIV diagnosis until after delivery. Additionally, while this
study found an increase in prenatal HIV diagnosis across the
study period, just 83% of mothers were diagnosed before or
during the prenatal period in 2014 (40).
Following an evolution in national policy and an increase
in the availability of antiretrovirals over the last 20 years,
the use of ART during pregnancy has substantially increased
across many regions of Brazil. In the southeast region, the use
of combined ART increased from 0% in the period prior to
nationwide availability between 1990 and 1994 to 46.4%
between 1999 and 2000 (23). Kakehasi et al. (24) also observed
an increase in the use of prenatal ART over time in the south-
east region, from 66.7% in 1998 to 89.9% in 2005. A study
conducted in the south of the country, in the State of Rio
Grande do Sul, showed 60.7% prenatal ART adherence from
1998-2004 and 73.3% from 2005-2011 (35). Additionally, in
the northern region, the number of women receiving prenatal
ARVs increased from 70.8% in 1999-2000 to 79.4% in 2011 (13).
In Rio de Janeiro, the use of prenatal ART also increased
between 1997 and 2014, although 16.7% of HIV-infected
pregnant women did not use ART in 2014 (40).
In the northeast region, Cruz Gouveia et al. (16) emphasized
an increased risk of MTCT when pregnant women started the
medication in the third trimester of pregnancy. However, there
is a lack of information in the literature about the gestational age
when ART was initiated in other regions of the country.
2) Peripartum measures. In addition to the missed
opportunities in prenatal care, measures to prevent MTCT
during childbirth remain a challenge in Brazil. In the intra-
partum period, prevention measures are based on the method
of delivery (cesarean section is recommended for women with
a viral load41,000 copies/ml or an unknown viral load), the
time of ruptured membrane (ideally the rupture occurs in the
delivery room), the HIV rapid test (done for all pregnant
women who did not attend prenatal care or have unknown/
uncertain HIV status), and the administration of azidothymi-
dine (AZT) in the delivery room, both to the mother and the
baby (41).
Several studies have shown that elective cesarean section
is a protective factor for vertical transmission of HIV in Brazil
(13,16,37). Between 2006 and 2007 in the city of São Paulo,
vaginal delivery was chosen by 13.3% (6/45) of the pregnant
women who were using ARTwith an undetectable viral load.
Cesarean section was performed for 86.7% (39/45) of preg-
nant women—71.1% (32/45) elective, 13.3% (6/45) emer-
gency, and 2.2% (1/45) without prior knowledge (42). In a
retrospective study in the northern region between 1999 and
2011, 20.9% (200/959) of women delivered vaginally, 19.8%
(190/959) received an emergency cesarean section, and 59.3%
(569/959) received an elective cesarean section. For the women
who delivered by an elective cesarean section, the rate of MTCT
was 2.5%, while in the group that did not, this number
increased to 10.8% (13). A study by Kakehasi et al. (24) was
conducted from 1998-2005 in the capital of the southeast
region and showed a variation in the rates of elective cesarean
sections over the years, with an increase up to 2000, followed
by a downward trend in the following years of the study.
In 1998, 40% of deliveries were elective cesarean sections.
This number practically doubled by 2000 and then decreased
again, reaching 54.2% in 2005.Ta
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The use of intravenous AZT during delivery was also
directly associated with a reduction in the rates of MTCT
(13,14,17,37). In a study by Cruz Gouveia et al. (16) in the
northeast, 75% of pregnant women received intrapartum AZT
between 2000 and 2009, and the rate of MTCT decreased from
21.8% to 4.6% in women who received AZT during delivery.
In the north of the country, 80.6% of pregnant women
between 1999 and 2011 received intrapartum AZT (13). The
rate of MTCT for women who had not used intrapartum
AZTwas 19.6%, whereas the rate of MTCTwas just 3.3% for
those who had (13). In the southeast of the country, 53.1% of
women received AZT during delivery between 1997 and
2014, and the absence of intrapartum AZT was associated
with a 4.9-fold increase in the likelihood of MTCT (40).
A study by Lima et al. (37) in the northeast region demon-
strated that ARV use at the time of delivery increased
between 2000 and 2009, with 67% of the women receiving
AZT during delivery in 2009.
In addition, Cruz Gouveia et al. (16) emphasized prema-
ture birth (gestational age less than 37 weeks) as a risk factor
for MTCT. Out of 113 children born at less than 37 weeks,
16.8% were infected with HIV, while of those with gestational
ages greater than or equal to 37 weeks, only 8.7% were
infected. A study in the southern region of the country also
showed a significant association between membrane rupture
time and the reduction in vertical HIV transmission rates
over the years. From 1998-2004, membrane rupture time
was greater than 4 hours in 79.4% of the pregnant women
evaluated; in the period between 2005 and 2011, only
10.8% of women had membrane rupture times greater than
4 hours (35).
3) Postnatal care. In the postpartum phase, follow-up is
needed for both the mother, with continued HIV control and
care to ensure that she is not breastfeeding, as well as for the
newborn, who is required to receive oral AZT for four weeks
if the mother completed the prenatal prophylaxis. If prenatal
prophylaxis was not completed and/or the maternal viral
load is unknown or up to 1,000 copies/ml at delivery, since
2014, 3 doses of nevirapine have been added to this regimen
(43,44). The child’s HIV viral load should be measured at
four weeks of age and after four months. If both have
undetectable results, the child can be declared HIV negative.
Children exposed vertically to HIV should continue to
receive formula up to 6 months of age to avoid MTCT via
breastfeeding (42). Studies in Brazil have shown that missed
opportunities for the prevention of MTCT during the post-
partum period include breastfeeding (13,16,24), maternal
diagnosis of HIV after childbirth, and lack of ART for the
newborn (14,37,45).
A study was conducted by Kakehasi et al. (24) in the
southeast of the country and found that breastfeeding was
significantly more common in children infected with MTCT,
with 33.9% of HIV-infected infants being breastfed compared
to just 4.3% of uninfected children. The Brazilian Ministry of
Health protocol recommends against breastfeeding, and free
formula has been supplied for HIV-exposed infants since
2002; a study by Andrade et al. (13) evaluated births between
1999 and 2011 in the north of the country and another study
evaluated births between 1997 and 2014 in the southeast city
of Rio de Janeiro (40), and these studies found that app-
roximately 10% of HIV-exposed children were breastfed.
Both studies demonstrated that this was largely due to the
late diagnosis of maternal HIV. Additionally, Cavalcante
et al. (45) showed that among 10 women who did not have
access to prenatal care between 2002 and 2003 in the
northeast city of Fortaleza, only one of their infants was
not breastfed. In the study by Andrade et al. (13), a ten-fold
decrease in breastfeeding was observed between 1999 and
2011, although 3.2% of babies exposed to HIV were still
breastfeed in 2011.
4) Sociodemographic factors. In addition to the biolo-
gical factors associated with an increased risk of MTCT, it is
important to address several social factors that directly or
indirectly hinder pregnant women’s access to MTCT pre-
vention services (28).
In the northeast and central-west region of the country,
the low education level of pregnant women was highlighted
as a possible limiting factor for the full implementation of
preventative measures (14,30,37). Between 1994 and 2010,
a study carried out in the state of Sergipe in the northeast
region showed that 58.2% of HIV-infected pregnant women
had less than seven years of formal education completed
(14). It was similar in Goiânia between 1995 and 2001, where
it was shown that 82.4% of HIV-infected pregnant women
had less than eight years of schooling (30). In a descriptive
study conducted in Belo Horizonte between 2004 and 2005,
Lana et al. (46) concluded that women with less education
who depend on public health services are less likely to ini-
tiate prenatal care early in pregnancy or to complete the
recommended number of prenatal visits.
Among studies assessing the sociodemographics of HIV-
infected pregnant women, there was a great deal of homo-
geneity among family income, with the majority of women
coming from a household of one to two and a half times
the monthly minimum wage. Nishimoto et al. (20) found an
average income of 2.5 times the minimum wage, with 29% of
women making a maximum of one minimum wage salary
per capita per month. According to Araujo et al. (28), despite
the significant decrease in poverty in Brazil in recent years,
the country remains with serious social, economic and cultural
inequities. These inequalities include disparities related to
the health system, and these disparities are evident regarding
access to prenatal care and greatly impede the success of
programs to prevent vertical transmission of HIV (28).
Finally, an important finding that serves as motivation for
the performance in the area of education appears in a study by
Fernandes et al. (21) in the southeast region: most pregnant
women (70.5%) are aware of the possibility of transmission of
HIV to their child. If this trend continues, it is hopeful that the
rate of prenatal adherence will increase and, in turn, the rate of
MTCT in Brazil will decrease.
5) Inadequacies in health services. In addition to the
sociodemographic characteristics of HIV-infected mothers,
inadequacies in preventative care for MTCTcan contribute to
increased MTCT rates. A study was carried out between 2004
and 2005 in a basic health unit in the northeast region in
the State of Ceará; this study highlighted that the deficit in
the recruitment of pregnant women, the delay in scheduling
prenatal visits by the community agent, and the delay in
completing the HIV test, and all constituted important
institutional barriers to MTCT prevention (47).
It is also worth noting the enormous importance of
making pregnant women feel welcome at health centers to
promote prenatal care uptake and adherence and to avoid
the first step in a cascade of missed opportunities. In a study
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by Darmont et al. (39), interviews with 40 pregnant women
from Rio de Janeiro in 2008 showed that many HIV-infected
women abandon care because of issues in healthcare deli-
very, such as excessive bureaucracy to make an appointment,
the high turnover of health professionals at health posts, and
no prioritization of care for pregnant women.
Additionally, a study by Farias et al. (48) evaluated the
knowledge of MTCT prevention measures in obstetricians at
public maternity hospitals in Salvador in 2005 and found
that only 82% reported a full understanding of the Ministry
of Health’s recommendations. The factors that prevented the
completion of preventative measures were assessed, and
74.4% of obstetricians reported inadequate prenatal follow-
up visits, 50% said it was due to a lack of information obtained
during prenatal care at the time of maternity admission, 42.6%
reported work overload, and 9% cited an inadequate disclo-
sure of recommendations. The lack of training programs was
also raised by 38.8% of these professionals since only 41.9%
of those interviewed attended a course or internship for HIV
training.
’ DISCUSSION
In the present review, we found that the reported rates of
MTCT varied considerably across different regions of Brazil,
ranging from 1.8% in a cohort from the northeast region to
28.8% in a cohort from the central-west region. Further eva-
luation indicated that these regional differences were largely
due to the period in which the study was conducted, as
studies directly comparing MTCT rates over time demon-
strated a decrease in cases over the years, similar to global
reductions in MTCT rates (49). However, a multicenter study
carried out in Brazil between 2008 and 2009 indicated that
the interregional differences in MTCT rates also occurred
even within the same study period, with the north and north-
east regions having much higher rates of MTCT (8-18%) than
the south and central-west regions (4-7%) (50). Moreover,
disparities were apparent even within the same region, with
higher rates of MTCT in metropolitan regions (25,28).
Assessing risk factors for the prevention of MTCT, we
identified missed opportunities across regions in the pre-
natal, peripartum, and postnatal periods. Although reduc-
tions in these missed opportunities were observed over time,
global goals for the elimination of MTCT (51) are still not
being met.
For the MTCT prevention routine to be effective, early
diagnosis is essential. Easy access to and robust services in
prenatal care remain the main pillars in the reduction in
MTCT. We found that attendance in prenatal care across
regions ranged fromB70-90%. Two studies were conducted,
one in the southeast city of Rio de Janeiro (40) and one in the
northeast state of Ceará (37), and both demonstrated an
increase in prenatal care engagement over time. In 2011, the
Stork Network (‘‘Rede Cegonha’’) was introduced to expand
and improve MTCT prevention services across Brazil. The
one study we identified that presented prenatal attendance
data after the creation of the Stork Network (40) found an
improvement in prenatal attendance from 2011-2014, but in
2014, only 83% of HIV-infected pregnant women had atten-
ded at least one prenatal visit. Additional recently conducted
research is needed to determine whether the improvement in
prenatal attendance following the creation of the Stork
Network has continued and whether the global goals of 95%
engagement in prenatal care (51) will be met in Brazil.
Despite the recent global increase in the number of preg-
nant women using ARVs, it is still estimated that more than
20% of pregnant women in the world are not receiving these
medications to prevent MTCT (49). In addition, in the same
year in Latin America and the Caribbean, the percentage of
pregnant women with HIV receiving some ARVs during
pregnancy was just 54% and 52%, respectively (8). In Brazil,
we found substantial improvements in the use of prenatal
ART in the years following the introduction of universal, free
access to HAART in 1997. Moreover, one study (40) eva-
luated MTCT prevention after the 2012 adoption of Option
B+ (lifelong triple ART to HIV-infected pregnant women)
and showed continued increases in prenatal ART use.
Nevertheless, in 2014, prenatal ART coverage was 83%,
below the global elimination target of 90% (51). Similar to
engagement in prenatal care, it will be important for ongoing
studies to determine if the use of prenatal ART has continued
to increase in other regions of Brazil and in more recent years
or if additional efforts are needed to reach global goals.
With regard to preventative services in the peripartum
period, we found that cesarean sections have decreased over
the years in Brazil (24). While these low rates of cesarean
sections may reflect a missed opportunity for the prevention
of MTCT, these data may also reflect the increased use of
prenatal ART and, in turn, an increased control of maternal
viral loads during the peripartum period over the years.
Further research will need to be carried out to determine the
percentage of women requiring but not receiving cesarean
sections for MTCT prevention throughout Brazil. In the
postnatal period, missed opportunities, including breast-
feeding (13,16,24,40) and a lack of ART for the newborn
(14,37,45), were observed and were most often due to the
maternal diagnosis not occurring until the postnatal period.
Together, these findings on missed opportunities in the
peripartum and postnatal periods highlight the importance
of prenatal care and early maternal diagnosis in ensuring
that all prophylactic measures are performed.
Among the articles analyzed, very few presented informa-
tion about sociodemographic factors related to the preven-
tion of MTCT. In future studies, sociodemographic factors
associated with the increased risk of MTCT, especially factors
that make it difficult for pregnant women to access or
continue prenatal care, will need to be determined to guide
new public health measures to target vulnerable populations.
An important limitation of the studies reviewed is that
most lacked information on the week of gestation in which
ART was initiated, which is fundamental to the analysis of
uptake and the quality of prenatal care offered. Additionally,
the analysis of the data presented here should be done with
caution since the data mainly reflect information from large
cities and reference centers and may not represent the reality
of the entirety of Brazil. For example, in the northern region,
the two articles analyzed were carried out in Manaus, and
we did not find information about other cities. For a more
complete understanding of missed opportunities in the pre-
vention and risk factors for MTCT nationwide, new studies
should be directed to less explored regions.
Our review of studies throughout Brazil shows a sub-
stantial drop in the rates of MTCT and an increase in
adherence to prophylactic measures over the years. Despite
this, there are still many pregnant women who do not benefit
from all the recommended interventions for HIV prevention
(32). To achieve the global elimination of MTCT goal (51), it is
essential to improve and facilitate the population’s access to
8
Prevention of vertical transmission of HIV
Guimara˜es MF et al.
CLINICS 2019;74:e318
prenatal care. Through these measures, it will be possible to
provide an early diagnosis and promote the completion of all
MTCT preventative measures.
’ ACKNOWLEDGMENTS
We thank Dr. Lee W. Riley (University of California, Berkeley) for providing
invaluable technical guidance and encouragement to the authors. KLL was
supported by the NIH Research Training Grant R25 TW009338, by a
Fulbright Postdoctoral Scholarship and by the Brazilian Federal Agency for
Support and Evaluation of Graduate Education (CAPES).
’ AUTHOR CONTRIBUTIONS
Guimarães MF and Lavero KL selected the articles to read. Guimarães
MF, Avelar JG, Pires LL, Oliveira GRT, Cosme EM, Salviato CM,
Oliveira TRD and Cabrera NB read the articles, organized and interpreted
the data, and wrote the manuscript. Guimarães MF, Avelar JG, Pires LL,
Oliveira GRT and Cosme EM formatted the version to be published.
Lavero KL and Cardoso CAA contributed to the conception and relevant
critical revision of the intellectual content. All authors contributed to the
ﬁnal approval of the manuscript to be published.
’ REFERENCES
1. Joint United Nations Program on HIV/AIDS. Global Aids Response
Progress Reporting 2016. Construction of core indicators for monitoring
the 2011 United Nations Political Declaration on HIV and AIDS. Inter-
national cooperation. January 2016, Geneva, Switzerland. [Accessed
March 1st, 2017]. Available from: https://aidsreportingtool.unaids.org/
2. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and
outcomes of HIV serostatus disclosure among women in developing
countries: implications for prevention of mother-to-child transmission
programmes. Bull World Health Organ. 2004;82(4):299-307.
3. Ministério da Saúde - Secretaria de Vigilância em Saúde - Departamento
de Vigilância, Prevenc¸ão e Controle das Infecc¸ões Sexualmente Trans-
missíveis, do HIV/Aids e das Hepatites Virais. Boletim epidemiológico -
Aids e IST. Volume XX. [Accessed Jul 3rd, 2017]. Available from: http://
www.aids.gov.br.
4. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al.
Prevention of mother-to-child HIV transmission in resource-poor coun-
tries: translating research into policy and practice. JAMA. 2000;283(9):
1175-82. https://doi.org/10.1001/jama.283.9.1175
5. [No authors listed]. Recommendations of the U.S. Public Health Service Task
Force on the use of zidovudine to reduce perinatal transmission of human
immunodeficiency virus. MMWR Recomm Rep. 1994;43(RR-11):1-20.
6. de Brito AM, de Sousa JL, Luna CF, Dourado I. [Trends in maternal-infant
transmission of AIDS after antiretroviral therapy in Brazil]. Rev Saude
Publica. 2006;(Suppl):18-22. https://doi.org/10.1590/S0034-89102006000
800004
7. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al.
Reduction of maternal-infant transmission of human immunodeficiency
virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials
Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173-80.
https://doi.org/10.1056/NEJM199411033311801
8. World Health Organization. PMTCT Strategic Vision 2010–2015. Pre-
venting mother-to-child transmission of HIV to reach the UNGASS and
Millennium Development Goals. [Accessed March 3rd, 2017]. Available
from: http://www.who.int/hiv/pub/mtct/strategic_vision.pdf?ua=1
9. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa
Nacional de DST e Aids. Recomendac¸ões para Profilaxia da Transmissão
Vertical do HIV e Terapia Antirretroviral em Gestantes: manual de bolso/
Ministério da Saúde, Secretaria de Vigilância em Saúde, Programa
Nacional de DST e Aids. – Brasília: Ministério da Saúde, 2010. 172 p.: il. –
(Série Manuais, n. 46). [Accessed March 1st, 2017]. Available from: http://
bvsms.saude.gov.br/bvs/publicacoes/recomendacoes_profilaxia_trans
missao_vertical_hiv_5ed.pdf
10. Brazilian Ministry of Health. Secretariat of Health Surveillance. Depart-
ment of STD, AIDS and Viral Hepatitis. Global AIDS Response. Progress
Reporting; Narrative Reporting. Brazil. 2014. [Accessed March 1st, 2017].
Available from: http://www.unaids.org/sites/default/files/country/
documents/BRA_narrative_report_2014.pdf
11. United Nations Children Fund. HIV/AIDS key global charts and figures.
Geneva: UNICEF; 2016. [Accessed March 1st, 2017]. Available from:
https://data.unicef.org/wp-content/uploads/2015/12/2015-Children-
Adolescents-and-AIDS-Statistical-Update-Executive-Summary_244.pdf
12. Soeiro CM, Miranda AE, Saraceni V, Lucena NO, Talhari S, Ferreira LC.
Mother-to-child transmission of HIV infection in Manaus, State of
Amazonas, Brazil. Rev Soc Bras Med Trop. 2011;44(5):537-41. https://doi.
org/10.1590/S0037-86822011000500001
13. de Andrade SD, Sabidó M, Marcelo Monteiro W, Canellas L, Prazeres V,
Schwartz Benzaken A. Mother-to-child Transmission of HIV From 1999 to
2011 in the Amazonas, Brazil: Risk Factors and Remaining Gaps in Pre-
vention Strategies. Pediatr Infect Dis J. 2016;35(2):189-95. https://doi.org/
10.1097/INF.0000000000000966
14. Lemos LM, Rocha TF, Conceic¸ão MV, Silva Ede L, Santos AH, Gurgel RQ.
Evaluation of preventive measures for mother-to-child transmission of
HIV in Aracaju, State of Sergipe, Brazil. Rev Soc Bras Med Trop. 2012;
45(6):682-6. https://doi.org/10.1590/S0037-86822012000600005
15. de Lemos LM, Lippi J, Rutherford GW, Duarte GS, Martins NG, Santos
VS, et al. Maternal risk factors for HIV infection in infants in northeastern
Brazil. Int J Infect Dis. 2013;17(10):e913-8. https://doi.org/10.1016/j.ijid.
2013.04.015
16. da Cruz Gouveia PA, da Silva GA, de Fatima Pessoa Militão de Albu-
querque M. Factors associated with mother-to-child transmission of the
human immunodeficiency virus in Pernambuco, Brazil, 2000–2009. Trop
Med Int Health. 2013;18(3):276-85. https://doi.org/10.1111/tmi.12042
17. Patricio FR, Rutherford GW, Barreto JH, Rodamilans C, Badaró R. Effec-
tiveness of the prevention of mother-to-child HIV transmission in Bahia,
Brazil. Braz J Infect Dis. 2015;19(5):538-42. https://doi.org/10.1016/j.bjid.
2015.06.006
18. Brandão MN, Souza ES, de Brito RJ, Cavalcanti MM, Brandão MF,
Cavalcante e Cavalcante M. Challenges in preventing vertical HIV
transmission in Petrolina, Pernambuco and Juazeiro, Bahia. Rev Bras
Saude Matern Infant. 2016;16(3):313-24. https://doi.org/10.1590/1806-
93042016000300006
19. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Breastfeeding,
genetic, obstetric and other risk factors associated with mother-to-child
transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative
Study for Vertical Transmission of HIV-1. AIDS. 1998;12(5):513-20.
https://doi.org/10.1097/00002030-199805000-00013
20. Nishimoto TM, Eluf Neto J, Rozman MA. [Mother-to-child transmis-
sion of human immunodeficiency virus (HIV-I): evaluation of control
measures in the city of Santos]. Rev Assoc Med Bras. 2005;51(1):54-60.
https://doi.org/10.1590/S0104-42302005000100021
21. Fernandes RC, Araújo LC, Medina-Acosta E. [Prevention of vertical
HIV transmission in Campos dos Goytacazes, Rio de Janeiro, Brazil].
Cad Saude Publica. 2005;21(4):1153-9. https://doi.org/10.1590/S0102-
311X2005000400017
22. Miranda AE, Soares RA, Prado BC, Monteiro RB, Figueiredo NC. Mother
to child transmission of HIV in Vitória, Brazil: factors associated with
lack of HIV prevention. AIDS Care. 2005;17(6):721-8. https://doi.org/
10.1080/09540120500038033
23. Amaral E, Assis-Gomes F, Milanez H, Cecatti JG, Vilela MM, Pinto E Silva
JL. [Timely implementation of interventions to reduce vertical HIV
transmission: a successful experience in Brazil]. Rev Panam Salud Publica.
2007;21(6):357-64. https://doi.org/10.1590/S1020-49892007000500003
24. Kakehasi FM, Pinto JA, Romanelli RM, Carneiro M, Cardoso CS, Tavares
Mdo C, et al. Determinants and trends in perinatal human immunodefi-
ciency virus type 1 (HIV-1) transmission in the metropolitan area of Belo
Horizonte, Brazil: 1998 – 2005. Mem Inst Oswaldo Cruz. 2008;103(4):
351-7. https://doi.org/10.1590/S0074-02762008000400007
25. Veloso VG, Bastos FI, Portela MC, Grinsztejn B, João EC, Pilotto JH, et al.
HIV rapid testing as a key strategy for prevention of mother-to-child
transmission in Brazil. Rev Saude Publica. 2010;44(5):803-11. https://doi.
org/10.1590/S0034-89102010005000034
26. Vieira AC, Miranda AE, Vargas PR, Maciel EL. [HIV prevalence in
pregnant women and vertical transmission in according to socioeco-
nomic status, Southeastern Brazil]. Rev Saude Publica. 2011;45(4):644-51.
https://doi.org/10.1590/S0034-89102011005000041
27. Prestes-Carneiro LE, Spir PR, Ribeiro AA, Gonc¸alvez VL. HIV-1 mother-
to-child transmission and associated characteristics in a public maternity
unit in Presidente Prudente, Brazil. Rev Inst Med Trop Sao Paulo. 2012;
54(1):25-9. https://doi.org/10.1590/S0036-46652012000100005
28. Pires Araujo ES, Khalili Friedman R, Bastos Camacho LA, Derrico M,
Ismério Moreira R, Amaral Calvet G, et al. Cascade of access to
interventions to prevent HIV mother to child transmission in the metro-
politan area of Rio de Janeiro, Brazil. Braz J Infect Dis. 2014;18(3):252-60.
https://doi.org/10.1016/j.bjid.2013.11.002
29. Dal Fabbro MM, Cunha RV, Paniago AM, Lindenberg Ade S, Freitas GM,
Nogueira SA. Prospective study on the prevention of vertical transmission
of HIV in Campo Grande, Mato Grosso do Sul, Brazil, from 1996 to 2001.
Braz J Infect Dis. 2005;9(1):20-7. https://doi.org/10.1590/S1413-86702
005000100005
30. Turchi MD, Duarte Lda S, Martelli CM. Mother-to-child transmission of
HIV: risk factors and missed opportunities for prevention among preg-
nant women attending health services in Goiânia, Goiás State, Brazil.
Cad Saude Publica. 2007;23 (Suppl 3):S390-401. https://doi.org/10.1590/
S0102-311X2007001500007
31. Martínez AM, Hora VP, Santos AL, Mendoza-Sassi R, Von Groll A, Soares
EA, et al. Determinants of HIV-1 mother-to-child transmission in Southern
9
CLINICS 2019;74:e318 Prevention of vertical transmission of HIV
Guimara˜es MF et al.
Brazil. An Acad Bras Cienc. 2006;78(1):113-21. https://doi.org/10.1590/
S0001-37652006000100011
32. Tornatore M, Gonc¸alves CV, Mendoza-Sassi RA, Silveira JM, D’ávila NE,
Maas CG, et al. HIV-1 vertical transmission in Rio Grande, Southern
Brazil. Int J STD AIDS. 2010;21(5):351-5. https://doi.org/10.1258/ijsa.
2009.009033
33. Kupek E, de Oliveira JF. [Vertical transmission of HIV, syphilis and
hepatitis B in the municipality with the highest incidence of AIDS in
Brazil: a population-based study from 2002 to 2007]. Rev Bras Epidemiol.
2012;15(3):478-87. https://doi.org/10.1590/S1415-790X2012000300004
34. Hoffmann IC, Santos WM, Padoin SM, Barros SM. A five-year review of
vertical HIV transmission in a specialized service: cross-sectional study.
Sao Paulo Med J. 2016;134(6):508-12. https://doi.org/10.1590/1516-3180.
2016.0139140616
35. Rosa MC, Lobato RC, Gonc¸alves CV, Silva NM, Barral MF, Martinez AM,
et al. Evaluation of factors associated with vertical HIV-1 transmission.
J Pediatr (Rio J). 2015;91(6):523-8. https://doi.org/10.1016/j.jpedp.2015.
07.021
36. Menezes Succi RC. Mother-to-child transmission of HIV in Brazil during
the years 2000 and 2001: results of a multi-centric study. Cad Saude
Publica. 2007;23 Suppl 3:S379-89. https://doi.org/10.1590/S0102-311X
2007001500006
37. Lima AC, da Costa CC, Teles LM, Damasceno AK, Oriá MO. Avaliac¸ão
epidemiológica da prevenc¸ão da transmissão vertical do HIV. Acta
Paul Enferm. 2014;27(4):311-8. https://doi.org/10.1590/1982-01942014
00053
38. Lima BG, Pimentel CO. Qualidade do pré-natal de gestantes assistidas
numa maternidade pública de Salvador, 2000-2001. Rev Baiana Saude
Publ. 2003;27(1/2):50-9.
39. Darmont Mde Q, Martins HS, Calvet GA, Deslandes SF, Menezes JA.
[Adherence to prenatal care by HIV-positive women who failed to receive
prophylaxis for mother-to-child transmission: social and behavioral fac-
tors and healthcare access issues]. Cad Saude Publica. 2010;26(9):1788-96.
https://doi.org/10.1590/S0102-311X2010000900012
40. Lovero KL, de Oliveira TRD, Cosme EM, Cabrera NB, Guimarães MF, de
Avelar JG, et al. Retrospective analysis of risk factors and gaps in pre-
vention strategies for mother-to-child HIV transmission in Rio de Janeiro,
Brazil. BMC Public Health. 2018;18(1):1110. https://doi.org/10.1186/
s12889-018-6002-8
41. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa
Nacional de DST e Aids. Protocolo para a prevenc¸ão de transmissão
vertical de HIV e sífilis. Manual de bolso. Ministério da Saúde, Secretaria
de Vigilância em Saúde, Programa Nacional de DST e Aids – Brasília:
Ministério da Saúde, 2007. 180 p.: il. – (Série B. Textos Básicos de Saúde).
[Accessed March 3rd, 2017] Available from: http://bvsms.saude.gov.br/
bvs/publicacoes/protocolo_prevencao_transmissao_verticalhivsifilis_
manualbolso.pdf
42. Ramos VM, Figueiredo EN, Succi RC. [Barriers to control syphilis and
HIV vertical transmission in the health care system in the city of Sao
Paulo]. Rev Bras Epidemiol. 2014;17(4):887-98. https://doi.org/10.1590/
1809-4503201400040008
43. Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH,
et al. Three postpartum antiretroviral regimens to prevent intrapartum
HIV infection. N Engl J Med. 2012;366(25):2368-79. https://doi.org/
10.1056/NEJMoa1108275
44. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departa-
mento de Vigilância, Prevenc¸ão e Controle das Infecc¸ões Sexualmente
Transmissíveis, do HIV/Aids e das Hepatites Virais. Protocolo Clínico e
Diretrizes Terapêuticas para Manejo da Infecc¸ão pelo HIV em Crianc¸as e
Adolescentes. – Brasília: Ministério da Saúde, 2018. 218 p.: il. [Accessed
May 5th, 2019]. Available from: http://www.aids.gov.br/pt-br/pub/
2017/protocolo-clinico-e-diretrizes-terapeuticas-para-manejo-da-infeccao-
pelo-hiv-em-criancas-e
45. Cavalcante MS, Ramos Junior AN, Silva TM, Pontes LR. Transmissão
vertical do HIV em Fortaleza: revelando a situac¸ão epidemiológica em
uma capital do Nordeste. Rev Bras Ginecol Obstet. 2004;26(2):131-8.
https://doi.org/10.1590/S0100-72032004000200008
46. Lana FC, Lima AS. [Prevention evaluation of HIV vertical transmission in
Belo Horizonte, MG, Brazil]. Rev Bras Enferm. 2010;63(4):587-94. https://
doi.org/10.1590/S0034-71672010000400014
47. Araújo MA, Vieira NF, Silva RM. [HIV-testing for pregnant women
in a Family Health Unit in Fortaleza, Ceará]. Cien Saude Colet. 2008;
13(6):1899-906. https://doi.org/10.1590/S1413-81232008000600025
48. Farias JP, Franco A, Santos KP, Dourado I, Galvão-Castro B. [Prevention of
HIV vertical transmission: obstetricians’ attitude in Salvador, Brazil]. Rev
Bras Ginecol Obstet. 2008;30(3):135-41. https://doi.org/10.1590/S0100-
72032008005000003
49. UNAIDS 2016. Prevention Gap Report. [Accessed March 3rd, 2017].
Available from: http://www.unaids.org/sites/default/files/media_asset/
2016-prevention-gap-report_en.pdf
50. Kerr LR, Cavalcante Mdo S, Kendall C, Machado MM, Dourado MI,
Galvão M. Disparities in mother-to-child transmission in Northeast Brazil:
regional failures within successful country programs. AIDS Care. 2011;
23(6):771-4. https://doi.org/10.1080/09540121.2010.532534
51. World Health Organization. Global guidance on criteria and processes
for validation: elimination of mother-to-child transmission of HIV and
syphilis. 2017. Available from: http://www.who.int/reproductivehealth/
publications/emtct-hiv-syphilis/en/
10
Prevention of vertical transmission of HIV
Guimara˜es MF et al.
CLINICS 2019;74:e318
